ABT logo

Abbott Laboratories (ABT)

Profile

Full Name

Abbott Laboratories

Ticker Symbol

ABT

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.abbott.com

Employees

114000

Key Details

Price

$132.85(+0.63%)

Market cap

$231.14B(Mega cap)

Last Dividend

$0.59

TTM Dividend yield

1.72%

Annual revenue

$41.95B(+4.59% YoY)

Annual EPS

$7.64(+134.36% YoY)

PE ratio

17.23

Next earnings date

Jul 18, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $132.85
    ABT price is $132.85

    30-Day Relative Volume

    0.47
    ABT 30-day relative volume is 0.47

    Price Performance

    Price Today change

    +0.63%
    ABT price is up +0.63% today

    Price YTD change

    +17.45%
    ABT price is up +17.45% since January 1st

    Price 1-year change

    +31.89%
    ABT price is up +31.89% year-on-year

    Price 3-year change

    +13.85%
    ABT price is up +13.85% over the past 3 years

    Price Range

    Price All-time high

    $142.60
    ABT price is currently -6.84% below its historical high of $142.60

    Price 3-year low

    $89.67
    ABT price is currently +48.15% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $231.14B
    ABT market capitalization is $231.14 billion

    Market cap 3-year change

    +13.13%
    ABT market capitalization is up +13.13% over the past 3 years

    Market cap All-time high

    $250.14B
    ABT market capitalization is currently -7.60% below its historical high of $250.14 billion

    Market cap sector rank

    99.59%
    ABT market capitalization is higher than 99.59% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.01%
    ABT shares outstanding is up +0.01% year-on-year

    Shares Outstanding 3-Year Change

    -0.63%
    ABT shares outstanding is down -0.63% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.21
    ABT beta is 0.21

    200-day SMA

    $121.78
    ABT price is currently +9.09% above its 200-day simple moving average

    50-day SMA

    $130.19
    ABT price is currently +2.04% above its 50-day simple moving average

    RSI

    52.91
    ABT 14-day relative strength index is 52.91

    Volume

    0.47
    ABT 30-day relative volume is 0.47

    ATR

    $2.40
    ABT average true range is $2.40

    10-day Historical Volatility

    24.05%
    ABT 10-day historical volatility is 24.05%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.59
    ABT last dividend was $0.59 per share, with an ex-dividend date of April 15, 2025

    Next Dividend

    -
    ABT next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $2.20
    ABT annual dividend per share is $2.20

    Dividend per share Sector Rank

    72.09%
    ABT annual dividend per share is higher than 72.09% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +7.84%
    ABT annual dividend per share is up +7.84% year-on-year

    Dividend per share 3-Year Change

    +22.22%
    ABT annual dividend per share is up +22.22% over the past 3 years

    Dividend yield

    Dividend yield

    1.66%
    ABT annual dividend yield is 1.66%

    Dividend yield Sector Rank

    41.18%
    ABT annual dividend yield is higher than 41.18% of companies in Healthcare sector

    Other

    Payout ratio

    28.62%
    ABT annual payout ratio is 28.62%

    Dividends paid

    $3.84B
    ABT annual dividends paid is $3.84 billion

    Free cash flow

    $6.35B
    ABT annual free cash flow is $6.35 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $41.95B
    ABT annual revenue is $41.95 billion

    Revenue Analysts estimate

    $44.62B
    ABT annual revenue is currently -5.99% lower than the consensus analysts' forecast

    Revenue 1-year change

    +4.59%
    ABT annual revenue is up +4.59% year-on-year

    Revenue Sector rank

    97.5%
    ABT annual revenue is higher than 97.5% of companies in Healthcare sector

    EPS

    EPS

    $7.64
    ABT annual earnings per share is $7.64

    EPS Analysts estimate

    $5.15
    ABT annual earnings per share is currently +48.25% higher than the consensus analysts' forecast

    EPS 1-year change

    +134.36%
    ABT annual earnings per share is up +134.36% year-on-year

    EPS Sector rank

    97.44%
    ABT annual earnings per share is higher than 97.44% of companies in Healthcare sector

    Profit

    Gross profit

    $23.24B
    ABT annual gross profit is $23.24 billion

    Gross margin

    55.41%
    ABT annual gross profit margin is 55.41%

    Operating profit

    $6.83B
    ABT annual operating income is $6.83 billion

    Operating margin

    16.27%
    ABT annual operating profit margin is 16.27%

    Net income

    $13.40B
    ABT annual net profit is $13.40 billion

    Net margin

    31.95%
    ABT annual net profit margin is 31.95%

    Expenses

    Total expenses

    $35.13B
    ABT annual total expenses is $35.13 billion

    Operating expenses

    $16.42B
    ABT annual total operating expenses is $16.42 billion

    Cost of goods sold

    $18.71B
    ABT annual cost of goods sold is $18.71 billion

    Selling, general & administrative expenses

    $11.70B
    ABT annual SGA is $11.70 billion

    Depreciation and amortization

    $3.22B
    ABT annual depreciation & amortization is $3.22 billion

    Interest expense

    $559.00M
    ABT annual interest expense is $559.00 million

    Income tax

    -$6.39B
    ABT annual income tax is -$6.39 billion

    EBIT & EBITDA

    EBIT

    $7.23B
    ABT annual earnings before interest & taxes is $7.23 billion

    EBITDA

    $9.11B
    ABT annual EBITDA is $9.11 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $81.41B
    ABT annual total assets is $81.41 billion

    Non current assets

    $57.76B
    ABT annual long term assets is $57.76 billion

    Current assets

    $23.66B
    ABT annual total current assets is $23.66 billion

    Cash and cash equivalents

    $7.62B
    ABT annual cash & cash equivalents is $7.62 billion

    Accounts receivable

    $6.92B
    ABT annual accounts receivable is $6.92 billion

    Inventory

    $6.19B
    ABT annual inventory is $6.19 billion

    Liabilities

    Total liabilities

    $33.51B
    ABT annual total liabilities is $33.51 billion

    Long term liabilities

    $19.36B
    ABT annual total long term liabilities is $19.36 billion

    Current liabilities

    $14.16B
    ABT annual total current liabilities is $14.16 billion

    Accounts payable

    $4.20B
    ABT annual accounts payable is $4.20 billion

    Debt

    Total debt

    $15.02B
    ABT annual total debt is $15.02 billion

    Total debt 1-year change

    -3.88%
    ABT annual total debt is down -3.88% year-on-year

    Long term debt

    $13.52B
    ABT annual long term debt is $13.52 billion

    Short term debt

    $1.50B
    ABT annual short term debt is $1.50 billion

    Equity & Capital

    Shareholders equity

    $47.66B
    ABT annual stockholders equity is $47.66 billion

    Book value

    $47.66B
    ABT annual book value is $47.66 billion

    Retained earnings

    $47.26B
    ABT annual retained earnings is $47.26 billion

    Working capital

    $9.50B
    ABT annual working capital is $9.50 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $8.56B
    ABT annual cash flow from operations is $8.56 billion

    Cash from operations 1-year change

    +17.86%
    ABT annual cash flow from operations is up +17.86% year-on-year

    Cash from investing

    -$2.34B
    ABT annual cash flow from investing activities is -$2.34 billion

    Cash from investing 1-year change

    +25.38%
    ABT annual cash flow from investing activities is up +25.38% year-on-year

    Cash from financing

    -$5.40B
    ABT annual cash flow from financing activities is -$5.40 billion

    Cash from financing 1-year change

    +23.79%
    ABT annual cash flow from financing activities is up +23.79% year-on-year

    CAPEX

    CAPEX

    $2.21B
    ABT annual capital expenditures is $2.21 billion

    CAPEX 1-year change

    +0.23%
    ABT annual capital expenditures is up +0.23% year-on-year

    Free Cash Flow

    Free cash flow

    $6.35B
    ABT annual free cash flow is $6.35 billion

    Free cash flow 1-year change

    +25.54%
    ABT annual free cash flow is up +25.54% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    55.41%
    ABT annual gross profit margin is 55.41%

    Operating margin

    16.27%
    ABT annual operating profit margin is 16.27%

    Net margin

    31.95%
    ABT annual net profit margin is 31.95%

    ROA & ROE

    ROA

    17.33%
    ABT annual return on assets is 17.33%

    ROE

    30.91%
    ABT annual return on equity is 30.91%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    17.23
    ABT price to earnings ratio is 17.23

    PE ratio Sector rank

    37.09%
    ABT price to earnings ratio is higher than 37.09% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.74
    ABT price to book ratio is 4.74

    PB ratio Sector rank

    80.72%
    ABT price to book ratio is higher than 80.72% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.46
    ABT price to sales ratio is 5.46

    PS ratio Sector rank

    66.71%
    ABT price to sales ratio is higher than 66.71% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $237.85B
    ABT enterprise value is $237.85 billion

    Enterprise value Sector rank

    99.42%
    ABT enterprise value is higher than 99.42% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    21.48
    ABT EV/EBITDA is 21.48

    EV/EBITDA Sector rank

    92.68%
    ABT EV/EBITDA is higher than 92.68% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.67
    ABT annual current ratio is 1.67

    Quick ratio

    1.23
    ABT annual quick ratio is 1.23

    Leverage

    Debt to equity

    0.30
    ABT annual debt to equity ratio is 0.30

    Interest coverage ratio

    12.93
    ABT annual interest coverage ratio is 12.93

    Risk & Stability

    Piotroski F-Score

    6
    ABT piotroski f-score is 6

    Altman Z-Score

    5.90
    ABT altman z-score is 5.90

    Analyst ratings

    Recent major analysts updates

    Apr 17, 25 Wells Fargo
    Overweight
    Apr 17, 25 Stifel
    Buy
    Apr 17, 25 Raymond James
    Outperform
    Apr 17, 25 RBC Capital
    Outperform
    Apr 17, 25 Piper Sandler
    Overweight
    Apr 17, 25 Morgan Stanley
    Equal-Weight
    Apr 17, 25 Jefferies
    Hold
    Apr 17, 25 Barclays
    Overweight
    Mar 10, 25 B of A Securities
    Buy
    Mar 4, 25 Goldman Sachs
    Buy

    Institutional Ownership

    Screeners with ABT included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Most recommended stocks
    Best performing stocks last 5 years
    S&P 500 companies
    Stocks below analysts price target
    Highest Market Cap Stocks
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Abbott Laboratories?
    • Does Abbott Laboratories pay dividends?
    • What sector is Abbott Laboratories in?
    • What industry is Abbott Laboratories in?
    • What country is Abbott Laboratories based in?
    • When did Abbott Laboratories go public?
    • Is Abbott Laboratories in the S&P 500?
    • Is Abbott Laboratories in the NASDAQ 100?
    • Is Abbott Laboratories in the Dow Jones?
    • When was Abbott Laboratories's last earnings report?
    • When does Abbott Laboratories report earnings?
    • Should I buy Abbott Laboratories stock now?

    What is the ticker symbol for Abbott Laboratories?

    The ticker symbol for Abbott Laboratories is NYSE:ABT

    Does Abbott Laboratories pay dividends?

    Yes, Abbott Laboratories pays dividends. The last payment was $0.59, with an ex-dividend date on April 15, 2025

    What sector is Abbott Laboratories in?

    Abbott Laboratories is in the Healthcare sector

    What industry is Abbott Laboratories in?

    Abbott Laboratories is in the Medical Devices industry

    What country is Abbott Laboratories based in?

    Abbott Laboratories is headquartered in United States

    When did Abbott Laboratories go public?

    Abbott Laboratories's initial public offering (IPO) was on March 17, 1980

    Is Abbott Laboratories in the S&P 500?

    Yes, Abbott Laboratories is included in the S&P 500 index

    Is Abbott Laboratories in the NASDAQ 100?

    No, Abbott Laboratories is not included in the NASDAQ 100 index

    Is Abbott Laboratories in the Dow Jones?

    No, Abbott Laboratories is not included in the Dow Jones index

    When was Abbott Laboratories's last earnings report?

    Abbott Laboratories's most recent earnings report was on Apr 16, 2025

    When does Abbott Laboratories report earnings?

    The next expected earnings date for Abbott Laboratories is Jul 18, 2025

    Should I buy Abbott Laboratories stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page